- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis ; volume:10 ; number:1 ; day:29 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (29.10.2022), 1-11, 12.2022
- Urheber
-
Teske, Nina C.
Engelen-Lee, Joo-Yeon
Dyckhoff-Shen, Susanne
Pfister, Hans-Walter
Klein, Matthias
Beek, Diederik van de
Kirschning, Carsten K.
Koedel, Uwe
Brouwer, Matthijs C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-022-01461-1
- URN
-
urn:nbn:de:101:1-2023011409211687273170
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Teske, Nina C.
- Engelen-Lee, Joo-Yeon
- Dyckhoff-Shen, Susanne
- Pfister, Hans-Walter
- Klein, Matthias
- Beek, Diederik van de
- Kirschning, Carsten K.
- Koedel, Uwe
- Brouwer, Matthijs C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Influence of delivery on plasminogen activator inhibitor activity
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis.
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
Influence of delivery on plasminogen activator inhibitor activity
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis.
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
Influence of delivery on plasminogen activator inhibitor activity
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis.
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)